From September 26, 2023 to September 30, 2023, the company has repurchased 311,958 shares, representing 0.18% for CNY 35.02 million. With this, the company has completed the repurchase of 311,958 shares, representing 0.18% for CNY 35.02 million under the buyback announced on September 27, 2023.
Shanghai Haohai Biological Technology Co., Ltd.
Equities
6826
CNE100001W69
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.65 HKD | -1.42% | +1.83% | +3.35% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.35% | 2.04B | |
-4.98% | 185B | |
-0.86% | 109B | |
-3.81% | 68.54B | |
+3.91% | 51.74B | |
+9.48% | 45.22B | |
+3.12% | 41.74B | |
+3.86% | 26.83B | |
+3.68% | 26.69B | |
+11.62% | 25.63B |
- Stock Market
- Equities
- 6826 Stock
- News Shanghai Haohai Biological Technology Co., Ltd.
- Tranche Update on Shanghai Haohai Biological Technology Co., Ltd.'s Equity Buyback Plan announced on September 27, 2023.